Director Schroeder Reports a $60 Million RVMD Purchase

Thilo Schroeder, director of Revolution Medicines $RVMD and managing member of Nextech Invest, made waves with a $60 million insider buy, acquiring 1.3 million shares.

Nextech, known for investing in cutting-edge life sciences companies, often backs transformative players in oncology. 

Schroeder's move underscores his confidence in RVMD’s potential.

Here’s The Hot Corner, with data from December 9, 2024:

Kevin Tang, President of Tang Capital Management, filed a Form 4 revealing a $10,822,000 purchase in Aurinia Pharmaceuticals Inc $AUPH.

Last but not least, the CEOs of MSCI Inc $MSCI and Biglari Holdings Inc $BH both filed Form 4s, revealing purchases of their own stock.